Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups
- PMID: 23286209
- DOI: 10.1111/jgh.12106
Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups
Abstract
Background and aim: The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.
Methods: We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.
Results: MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.
Conclusions: The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.
Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Similar articles
-
Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.Am J Gastroenterol. 2012 Apr;107(4):561-7. doi: 10.1038/ajg.2011.400. Epub 2011 Nov 22. Am J Gastroenterol. 2012. PMID: 22108448
-
Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis.J Cardiovasc Comput Tomogr. 2013 Sep-Oct;7(5):311-8. doi: 10.1016/j.jcct.2013.08.011. Epub 2013 Sep 26. J Cardiovasc Comput Tomogr. 2013. PMID: 24268118
-
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19. Metabolism. 2013. PMID: 22999011
-
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?World J Gastroenterol. 2013 Jun 14;19(22):3375-84. doi: 10.3748/wjg.v19.i22.3375. World J Gastroenterol. 2013. PMID: 23801829 Free PMC article. Review.
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.Diabet Med. 2007 Jan;24(1):1-6. doi: 10.1111/j.1464-5491.2007.02025.x. Diabet Med. 2007. PMID: 17227317 Review.
Cited by
-
Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.Redox Biol. 2016 Oct;9:296-305. doi: 10.1016/j.redox.2016.09.002. Epub 2016 Sep 9. Redox Biol. 2016. PMID: 27639112 Free PMC article.
-
Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.BMJ Open. 2015 Sep 22;5(9):e008204. doi: 10.1136/bmjopen-2015-008204. BMJ Open. 2015. PMID: 26395497 Free PMC article.
-
Heat Treatment Improves Hepatic Mitochondrial Respiratory Efficiency via Mitochondrial Remodeling.Function (Oxf). 2021 Jan 22;2(2):zqab001. doi: 10.1093/function/zqab001. eCollection 2021. Function (Oxf). 2021. PMID: 33629069 Free PMC article.
-
Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway.Drugs. 2015 Aug;75(12):1373-92. doi: 10.1007/s40265-015-0437-3. Drugs. 2015. PMID: 26201461 Free PMC article. Review.
-
Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats.Curr Issues Mol Biol. 2022 Apr 26;44(5):1889-1900. doi: 10.3390/cimb44050129. Curr Issues Mol Biol. 2022. PMID: 35678658 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical